EODData

NSE, GLAXO: GlaxoSmithKline Pharmaceuticals Limited

01 Oct 2025
LAST:

2,697

CHANGE:
 37.50
OPEN:
2,660
HIGH:
2,730
ASK:
0
VOLUME:
46.1K
CHG(%):
1.41
PREV:
2,660
LOW:
2,660
BID:
0
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
01 Oct 252,6602,7302,6602,69746.1K
30 Sep 252,6632,6942,6462,66058.2K
29 Sep 252,6702,7092,6232,66389.8K
26 Sep 252,7052,7052,6402,672229.6K
25 Sep 252,7442,7622,7252,73833.3K
24 Sep 252,7582,7652,7352,74638K
23 Sep 252,7642,7802,7312,76268.4K
22 Sep 252,7542,7802,7252,76281.2K
19 Sep 252,7682,7682,7302,74185.1K
18 Sep 252,7512,7752,7202,755110.3K

COMPANY PROFILE

Name:GlaxoSmithKline Pharmaceuticals Limited
About:GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.
Sector:Healthcare
Address:GSK House, Mumbai, India, 400030
Website:https://india-pharma.gsk.com
ISIN:INE159A01016

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:49.78
Price to Book:24.33
Price to Sales:12.64
EBITDA:11.735B
Shares:169.41M
Market Cap:456.922B

TECHNICAL INDICATORS

MA5:2,686.08
MA10:2,719.73
MA20:2,758.49
MA50:2,825.15
MA100:3,031.57
MA200:2,798.61
STO9:31.17
STO14:19.24
RSI14:23.84
WPR14:-67.19
MTM14:-76.80
ROC14:-0.03
ATR:56.93
Week High:2,765.00
Week Low:2,622.60
Month High:2,883.40
Month Low:2,622.60
Year High:3,515.70
Year Low:1,921.00
Volatility:9.21

RECENT SPLITS

Date Ratio
11 Sep 20182-1

RECENT DIVIDENDS

Date Amount
30 May 2025$42.00
31 May 2024$32.00
30 Jun 2023$32.00
07 Jul 2022$30.00
19 Jul 2021$30.00
17 Jul 2020$20.00
11 Jul 2019$20.00
13 Jul 2018$8.75
14 Jul 2017$7.50
15 Jul 2016$12.50